Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clin...
Leadership
Walter V. KlempFounder
Co-Founder, Chairman, President & CEO
Jonathan P. Foster CPA
Executive VP & CFO
Donald H. Picker Ph.D.
Chief Scientific Officer
Waldemar Priebe Ph.D.Founder
Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board
